title: Role of zoledronic acid in the prevention and treatment of osteoporosis.
abstract: Taken once a year, intravenous zoledronic acid (Zol) (Reclast® or Aclasta®) is a third-generation nitrogen-containing bisphosphonate that is effective compared with placebo in reducing the risk of fractures in patients with postmenopausal osteoporosis and recent low-trauma hip fracture. In glucocorticoid-induced osteoporosis, there is no significant difference between Zol and risedronate for new fractures. Improvements in bone mineral density and early reduction of bone remodeling markers are observed in postmenopausal osteoporosis, recent low-trauma hip fracture, and glucocorticoid-induced osteoporosis. Given that Zol is generally well tolerated and very convenient, it is an interesting therapeutic option for aging patients who take multiple oral drugs, who have adherence or gastrointestinal tolerance issues, and who have an indication for oral bisphosphonates. Zol is not recommended for patients with severe renal impairment. Vitamin D deficiency should be corrected before the administration of Zol.
authors: Department of Medicine, Centre de recherche du CHUM, Université de Montréal, Hôpital Saint-Luc, Montréal, QC, Canada.
authors: Agnès
authors: A
authors: Räkel
authors: Andrée
authors: A
authors: Boucher
authors: Louis-Georges
authors: LG
authors: Ste-Marie
references: Oncology (Williston Park). 1992 Sep;6(9):47-52; discussion 52-4
references: 1449976
references: N Engl J Med. 2007 May 3;356(18):1809-22
references: 17476007
references: CMAJ. 1996 Oct 1;155(7):921-3
references: 8837540
references: J Bone Miner Res. 2005 Jul;20(7):1185-94
references: 15940371
references: Clin Pharmacokinet. 2010 Aug;49(8):535-48
references: 20608755
references: J Pharmacol Exp Ther. 2001 Feb;296(2):235-42
references: 11160603
references: Bone. 1999 May;24(5 Suppl):81S-85S
references: 10321935
references: Osteoporos Int. 2000;11(7):556-61
references: 11069188
references: N Engl J Med. 2008 Mar 20;358(12):1304-6
references: 18354114
references: J Urol. 2003 Jun;169(6):2008-12
references: 12771706
references: Bone. 2007 May;40(5):1238-43
references: 17347063
references: Osteoporos Int. 2010 Jul;21(7):1277-85
references: 19802508
references: Bone. 2007 Jul;41(1):122-8
references: 17468062
references: Bone. 2010 Aug;47(2):169-80
references: 20493982
references: J Bone Joint Surg Br. 2007 Mar;89(3):349-53
references: 17356148
references: J Urol. 2009 Nov;182(5):2257-64
references: 19758618
references: J Bone Miner Res. 2011 Jan;26(1):12-8
references: 20645415
references: J Clin Pharmacol. 2003 Feb;43(2):154-62
references: 12616668
references: J Bone Miner Res. 2008 Jan;23(1):6-16
references: 17892374
references: Bone. 2006 May;38(5):617-27
references: 16046206
references: Clin Ther. 2007 Aug;29(8):1548-58
references: 17919538
references: J Bone Miner Res. 2009 Sep;24(9):1544-51
references: 19338427
references: N Engl J Med. 2002 Feb 28;346(9):653-61
references: 11870242
references: Mayo Clin Proc. 2006 Aug;81(8):1013-22
references: 16901023
references: Lancet. 2009 Apr 11;373(9671):1253-63
references: 19362675
references: J Clin Endocrinol Metab. 2009 Feb;94(2):538-44
references: 19050050
references: AIDS. 2010 Nov 13;24(17):2679-86
references: 20859192
references: Clin Ther. 2003 Nov;25(11):2669-708
references: 14693298
references: J Bone Miner Res. 2010 Nov;25(11):2267-94
references: 20842676
references: J Am Geriatr Soc. 2010 Feb;58(2):292-9
references: 20070415
references: CMAJ. 1997 Nov 15;157(10):1357-63
references: 9371065
references: J Am Dent Assoc. 2008 Jan;139(1):32-40
references: 18167382
references: Maturitas. 2004 Jul 15;48(3):271-87
references: 15207894
references: Kidney Int. 2008 Sep;74(5):641-8
references: 18509324
references: Osteoporos Int. 2007 Aug;18(8):1033-46
references: 17323110
references: J Orthop Trauma. 2008 May-Jun;22(5):346-50
references: 18448990
references: CMAJ. 2010 Nov 23;182(17):1864-73
references: 20940232
references: CMAJ. 2002 Nov 12;167(10 Suppl):S1-34
references: 12427685
references: Injury. 2008 Feb;39(2):224-31
references: 18222447
references: J Bone Miner Res. 2000 Aug;15(8):1467-76
references: 10934645
references: Can Assoc Radiol J. 2005 Jun;56(3):178-88
references: 16144280
references: Osteoporos Int. 1999;10(4):259-64
references: 10692972
references: Osteoporos Int. 2011 Feb;22(2):373-90
references: 21085935
references: N Engl J Med. 2010 May 13;362(19):1761-71
references: 20335571
references: Obstet Gynecol. 2009 Nov;114(5):999-1007
references: 20168099
references: N Engl J Med. 2007 Nov 1;357(18):1799-809
references: 17878149
references: J Clin Pharmacol. 2002 Nov;42(11):1228-36
references: 12412821
references: J Urol. 2002 May;167(5):1952-6
references: 11956415
references: Drug Saf. 2001 Jan;24(1):19-38
references: 11219485
references: Clin Pharmacol Ther. 1995 Sep;58(3):288-98
references: 7554702
references: Ann Intern Med. 2006 May 16;144(10):753-61
references: 16702591
references: Arch Intern Med. 1991 Oct;151(10):2026-32
references: 1929691
references: Am J Med. 2007 Mar;120(3):251-6
references: 17349448
references: J Bone Miner Res. 2010 Oct;25(10):2239-50
references: 20499357
references: J Clin Endocrinol Metab. 2009 Sep;94(9):3215-25
references: 19567517